181 related articles for article (PubMed ID: 20645127)
1. Synthesis of PEGylated lactose analogs for inhibition studies on T.cruzi trans-sialidase.
Giorgi ME; Ratier L; Agusti R; Frasch AC; de Lederkremer RM
Glycoconj J; 2010 Jul; 27(5):549-59. PubMed ID: 20645127
[TBL] [Abstract][Full Text] [Related]
2. Improved bioavailability of inhibitors of Trypanosoma cruzi trans-sialidase: PEGylation of lactose analogs with multiarm polyethyleneglycol.
Giorgi ME; Ratier L; Agusti R; Frasch AC; de Lederkremer RM
Glycobiology; 2012 Oct; 22(10):1363-73. PubMed ID: 22653661
[TBL] [Abstract][Full Text] [Related]
3. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
Giorgi ME; de Lederkremer RM
Carbohydr Res; 2011 Sep; 346(12):1389-93. PubMed ID: 21645882
[TBL] [Abstract][Full Text] [Related]
4. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
[TBL] [Abstract][Full Text] [Related]
5. The trans-sialidase from Trypanosoma cruzi efficiently transfers alpha-(2-->3)-linked N-glycolylneuraminic acid to terminal beta-galactosyl units.
Agustí R; Giorgi ME; de Lederkremer RM
Carbohydr Res; 2007 Nov; 342(16):2465-9. PubMed ID: 17765882
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, molecular docking and biological evaluation of novel phthaloyl derivatives of 3-amino-3-aryl propionic acids as inhibitors of Trypanosoma cruzi trans-sialidase.
Kashif M; Chacón-Vargas KF; López-Cedillo JC; Nogueda-Torres B; Paz-González AD; Ramírez-Moreno E; Agusti R; Uhrig ML; Reyes-Arellano A; Peralta-Cruz J; Ashfaq M; Rivera G
Eur J Med Chem; 2018 Aug; 156():252-268. PubMed ID: 30006170
[TBL] [Abstract][Full Text] [Related]
7. Preliminary 1H NMR investigation of sialic acid transfer by the trans-sialidase from Trypanosoma cruzi.
Wilson JC; Kiefel MJ; Albouz-Abo S; von Itzstein M
Bioorg Med Chem Lett; 2000 Dec; 10(24):2791-4. PubMed ID: 11133093
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the differences of the hydrolytic activity of Trypanosoma cruzi trans-sialidase and Trypanosoma rangeli sialidase: a quantum mechanics-molecular mechanics modeling study.
Bueren-Calabuig JA; Pierdominici-Sottile G; Roitberg AE
J Phys Chem B; 2014 Jun; 118(22):5807-16. PubMed ID: 24814976
[TBL] [Abstract][Full Text] [Related]
9. Temperature differences for trans-glycosylation and hydrolysis reaction reveal an acceptor binding site in the catalytic mechanism of Trypanosoma cruzi trans-sialidase.
Ribeirão M; Pereira-Chioccola VL; Eichinger D; Rodrigues MM; Schenkman S
Glycobiology; 1997 Dec; 7(8):1237-46. PubMed ID: 9455925
[TBL] [Abstract][Full Text] [Related]
10. Galactosyl-lactose sialylation using Trypanosoma cruzi trans-sialidase as the biocatalyst and bovine κ-casein-derived glycomacropeptide as the donor substrate.
Wilbrink MH; ten Kate GA; van Leeuwen SS; Sanders P; Sallomons E; Hage JA; Dijkhuizen L; Kamerling JP
Appl Environ Microbiol; 2014 Oct; 80(19):5984-91. PubMed ID: 25063655
[TBL] [Abstract][Full Text] [Related]
11. Enzymatically inactive trans-sialidase from Trypanosoma cruzi binds sialyl and beta-galactopyranosyl residues in a sequential ordered mechanism.
Todeschini AR; Dias WB; Girard MF; Wieruszeski JM; Mendonça-Previato L; Previato JO
J Biol Chem; 2004 Feb; 279(7):5323-8. PubMed ID: 14634017
[TBL] [Abstract][Full Text] [Related]
12. Continuous nonradioactive method for screening trypanosomal trans-sialidase activity and its inhibitors.
Sartor PA; Agusti R; Leguizamón MS; Campetella O; de Lederkremer RM
Glycobiology; 2010 Aug; 20(8):982-90. PubMed ID: 20375068
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of a model trisaccharide for studying the interplay between the anti α-Gal antibody and the trans-sialidase reactions in Trypanosoma cruzi.
Giorgi ME; Lopez R; Agusti R; Marino C; de Lederkremer RM
Carbohydr Res; 2017 Oct; 450():30-37. PubMed ID: 28858610
[TBL] [Abstract][Full Text] [Related]
14. The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidase.
Chen Z; Marcé P; Resende R; Alzari PM; Frasch AC; van den Elsen JMH; Crennell SJ; Watts AG
Eur J Med Chem; 2018 Oct; 158():25-33. PubMed ID: 30199703
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis.
Buschiazzo A; Amaya MF; Cremona ML; Frasch AC; Alzari PM
Mol Cell; 2002 Oct; 10(4):757-68. PubMed ID: 12419220
[TBL] [Abstract][Full Text] [Related]
16. The role of natural selection in shaping genetic variation in a promising Chagas disease drug target: Trypanosoma cruzi trans-sialidase.
Gallant JP; Lima-Cordón RA; Justi SA; Monroy MC; Viola T; Stevens L
Infect Genet Evol; 2018 Aug; 62():151-159. PubMed ID: 29684709
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and enzymatic evaluation of 3-O-substituted aryl β-D-galactopyranosides as inhibitors of Trypanosoma cruzi trans-sialidase.
Silva BL; S Filho JD; Andrade P; Carvalho I; Alves RJ
Bioorg Med Chem Lett; 2014 Sep; 24(18):4529-4532. PubMed ID: 25149510
[TBL] [Abstract][Full Text] [Related]
18. Donor substrate binding to trans-sialidase of Trypanosoma cruzi as studied by STD NMR.
Blume A; Neubacher B; Thiem J; Peters T
Carbohydr Res; 2007 Sep; 342(12-13):1904-9. PubMed ID: 17597593
[TBL] [Abstract][Full Text] [Related]
19. Modulation of catalytic function by differential plasticity of the active site: case study of Trypanosoma cruzi trans-sialidase and Trypanosoma rangeli sialidase.
Demir O; Roitberg AE
Biochemistry; 2009 Apr; 48(15):3398-406. PubMed ID: 19216574
[TBL] [Abstract][Full Text] [Related]
20. The action of Trypanosoma cruzi trans-sialidase on glycolipids and glycoproteins.
Ferrero-García MA; Trombetta SE; Sánchez DO; Reglero A; Frasch AC; Parodi AJ
Eur J Biochem; 1993 Apr; 213(2):765-71. PubMed ID: 8477749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
